A Random, Open, Dose Finding and Pharmacokinetics/Pharmacodynamics(PK/PD) Phase II Study of Apatinib Tablets in the Treatment of Advanced Colorectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 06 Apr 2015
At a glance
- Drugs Rivoceranib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 01 Apr 2015 According to the ClinicalTrials.gov record, status changed from recruiting to completed.
- 15 Feb 2012 New trial record